A Measles-Vectored Vaccine Candidate Expressing Prefusion-Stabilized SARS-CoV-2 Spike Protein Brought to Phase I/II Clinical Trials: Candidate Selection in a Preclinical Murine Model.
JOURNAL OF VIROLOGY（2024）
Key words
COVID-19 vaccine,prefusion-stabilized spike,measles vector,vectored vaccine
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined